EZH2 is upregulated in various cancers, including medulloblastoma and glioblastoma, and it can act as a critical regulator of neoplastic proliferation, maintenance of stem cell-like features and inhibition of differentiation (Suvà et al., 2009; Vo et al., 2017). Here, EZH2 is linked to medulloblastoma.